EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 3.0

Interferon-α Treatment for Growing Teratoma Syndrome of the Testis

Masahiro Inoue, Shin-Ichi Hisasue, Mika Nagae, Toshiyuki China, Keisuke Saito, Shuji Isotani, Raizo Yamaguchi, Hisamitsu Ide, Satoru Muto, Shigeo Horie

Case Reports in Nephrology and Dialysis · 2013

DOI: 10.1159/000350897 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Nephrology and Dialysis, 2013. Verfasst von Masahiro Inoue und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Teikyo University School of Medicine, Tokyo, Japan. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 23-year-old man with a right scrotal mass and back pain was referred for further treatment after right radical orchiectomy for testicular cancer. CT scans brought by the patient showed extensive metastasis to the retroperitoneal lymph nodes with no lung involvement. α-Fetoprotein and human chorionic gonadotropin were elevated preoperatively (384 ng/ml and 112 mIU/ml, respectively). Confirmation of the histopathologic examination revealed a mixed germ cell tumor (95% immature teratoma and 5% embryonal carcinoma). We started the patient on chemotherapy with bleomycin, etoposide, and cisplatin (BEP). After a single course, tumor markers began to normalize, but there was radiologic evidence of continued growth of the retroperitoneal mass and new metastases in the lung. The patient was given 2 courses of salvage chemotherapy with etoposide, ifosfamide, and cisplatin (VIP). However, the mass and lung metastases continued to progress, and the patient was growing rapidly intolerant of the side effects of treatment (i.e., nausea, appetite loss, and pancytopenia). After thorough discussion with the patient and his family, we decided to start the patient on interferon (IFN)-α therapy. Natural, nonrecombinant IFN-α (OIF, Otsuka, Japan) 5,000,000 IU was administered twice weekly with approval of the ethics committee of our institution. The patient responded moderately with marked deceleration of tumor growth and stabilization of the lung metastases. He is alive and well at 16 months on IFN-α therapy.

Schlagwörter

Stichwörter der Autor:innen

Growing teratoma syndromeImmature teratomaInterferon-αTesticular tumor

Autor:innen und Institutionen

  • Department of Urology, Teikyo University School of Medicine, Tokyo, Japan.

Zitieren

APA

Inoue, M., Hisasue, S., Nagae, M., China, T., Saito, K., Isotani, S., Yamaguchi, R., Ide, H., Muto, S., & Horie, S. (2013). Interferon-α Treatment for Growing Teratoma Syndrome of the Testis. Case Reports in Nephrology and Dialysis. https://doi.org/10.1159/000350897

Vancouver

Inoue M, Hisasue S, Nagae M, China T, Saito K, Isotani S, et al. Interferon-α Treatment for Growing Teratoma Syndrome of the Testis. Case Reports in Nephrology and Dialysis. 2013. doi:10.1159/000350897

BibTeX
@article{Inoue2013,
  author = {Inoue, Masahiro and Hisasue, Shin-Ichi and Nagae, Mika and China, Toshiyuki and Saito, Keisuke and Isotani, Shuji and Yamaguchi, Raizo and Ide, Hisamitsu and Muto, Satoru and Horie, Shigeo},
  title = {Interferon-α Treatment for Growing Teratoma Syndrome of the Testis},
  journal = {Case Reports in Nephrology and Dialysis},
  year = {2013},
  doi = {10.1159/000350897}
}
Kostenlos starten →